Nano-X Imaging (NNOX) Stock Price, News & Analysis

Company Overview

Nano-X Imaging Ltd. is a medical technology company developing digital X-ray and medical imaging solutions. Its primary product is the Nanox.ARC, a digitally driven X-ray system designed to provide imaging capabilities in hospitals, clinics and other healthcare settings. The company’s approach is intended to support more accessible and affordable diagnostic imaging, including in locations where conventional radiology infrastructure may be limited.

Nano-X also offers cloud-based services through its Nanox.CLOUD platform, which is designed to connect imaging devices, manage examinations and facilitate the transmission and review of medical images. Through its Nanox.AI business, developed following the acquisition of Zebra Medical Vision, the company provides artificial intelligence tools intended to assist with the analysis of medical images and the identification of potential findings.

Founded in Israel, Nano-X serves healthcare providers and partners internationally and has pursued regulatory clearances and commercial deployments in multiple markets. The company was founded by Ran Poliakine, who has served in a leadership role as chairman, while Erez Nachtomy has served as chief executive officer. Nano-X Imaging is headquartered in Israel and is listed on the Nasdaq Capital Market under the symbol NNOX.

Key Stats

• Today's Range: $0.50 to $0.53
• 50-Day Range: $0.51 to $1.11
• 52-Week Range: $0.50 to $4.71
• Volume: 729,614 shs
• Average Volume: 872,183 shs
• Market Capitalization: $40.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.33
• Consensus Rating: Moderate Buy

Nano-X Imaging Stock Analysis - MarketRank™

Nano-X Imaging scored higher than 80% of companies evaluated by MarketBeat, and ranked 108th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nano-X Imaging has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 2 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Nano-X Imaging has a consensus price target of $4.33, representing about 742.1% upside from its current price of $0.51.

Amount of Analyst Coverage

Nano-X Imaging has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nano-X Imaging are expected to grow in the coming year, from ($1.23) to ($0.41) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nano-X Imaging is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nano-X Imaging is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nano-X Imaging has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

8.69% of the float of Nano-X Imaging has been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 7.03.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 6.76%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nano-X Imaging does not currently pay a dividend.

Dividend Growth

Nano-X Imaging does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

Nano-X Imaging has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Nano-X Imaging this week, compared to 6 articles on an average week.

MarketBeat Follows

Only 8 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

Company Ownership

• Score: 3.8 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Nano-X Imaging in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $150,006.00 in company stock, which represents 0.3709% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Nano-X Imaging insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,006.00 in company stock and sold $0.00 in company stock.

Percentage Held by Institutions

21.49% of the stock of Nano-X Imaging is held by institutions.

Company Calendar

• Last Earnings: 9/09/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 11/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:NNOX
• CIK: 1795251
• Web: www.nanox.vision
• Phone: 972-02-536-0360
• Fax: 972-02-544-5214
• Employees: 197
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Nano-X Imaging: $4.33
• High Price Target: $5.00
• Low Price Target: $3.00
• Potential Upside/Downside: +742.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.14)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$75.02 million
• Net Margins: -926.05%
• Pretax Margin: -758.47%
• Return on Equity: -116.93%
• Return on Assets: -100.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.84
• Quick Ratio: 2.59

Sales & Book Value

• Annual Sales: $13.02 million
• Price / Sales: 3.11
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.01 per share
• Price / Book: 0.26

Miscellaneous

• Outstanding Shares: 78,590,000
• Free Float: N/A
• Market Cap: $40.44 million
• Optionable: Optionable
• Beta: 1.28